DiscGenics is a biotechnology company developing advanced spinal therapeutics to treat patients with diseases of the intervertebral disc.


We are currently developing IDCT, a novel off-the-shelf injectable therapeutic based on regenerative medicine and progenitor cell science to treat pain associated with degenerative disc disease.


Learn about tissue engineering and adult stem cells.


Find out more about the DiscGenics Team!


Want more info?

Latest News...

DiscGenics selected as a finalist for Red Herring Top 100 North America 2014


See more news